The synthetic biology concept continued to be strong. Blue Biotech had 3 consecutive sales, Channing Biotech surged 15%, and Langkun Environmental, Fuxiang Pharmaceutical, and Jiabiyou had advanced gains.
合成生物概念延续强势，蔚蓝生物3连板，川宁生物大涨15%，朗坤环境、富祥药业、嘉必优等涨幅靠前。
The synthetic biology concept continued to be strong. Blue Biotech had 3 consecutive sales, Channing Biotech surged 15%, and Langkun Environmental, Fuxiang Pharmaceutical, and Jiabiyou had advanced gains.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.